A number of stocks jumped in the afternoon session after shares of enterprise software and SaaS companies rallied broadly as investors rotated capital out of semiconductor and AI-hardware stocks following calls for an artificial intelligence development slowdown.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

A sharp split between software and large-cap tech is driving unusual gains across enterprise AI names today, and the reason behind it traces back to a weekend argument among the world's top AI researchers.

CrowdStrike commands a premium valuation that its growth and free cash flow continue to justify. UiPath just turned consistently profitable but is still working to convince investors that the growth story is intact.

Citi just slapped a Buy rating on UiPath with a target nearly 70% above the current price, yet shares keep falling. Here is what the bull and bear camps are fighting over ahead of a high-stakes investor day that could flip the narrative.

Citi recommends buying UiPath stock on the post-earnings selloff. Here’s why analyst Yitchuin Wong remains bullish on PATH shares.

Wall Street just raised price targets on UiPath across the board after a strong earnings beat, yet not a single analyst upgraded the stock. Here is why four simultaneous target hikes are actually a bearish signal for automation software investors.

PATH's 24% post-earnings slide contrasts with a revenue beat, raised annual guidance and stronger profitability, creating a potential entry point.
Wall Street remains cautious about whether AI can drive faster growth and stronger revenue for UiPath.

UiPath shares tumbled after its fiscal Q2 earnings report.

UiPath (PATH) is back in focus after its latest quarterly report. The company paired second quarter earnings with higher full year revenue guidance, AI heavy deal activity, and a planned CFO transition. UiPath’s share price has been volatile around the earnings release, with the stock moving higher by 29.22% over the past 30 days and 62.10% over 90 days. The 1 year total shareholder return of 67.93% points to momentum that has been building rather than fading. Compare UiPath’s AI driven...

Shares of automation software firm UiPath rose Thursday after it beat analyst expectations for its second quarter revenue while matching estimates for earnings per share. The stock has risen nearly 70% over the past year, but is up just 12% this year as concerns that artificial intelligence will hurt software firm’s revenue have weighed on the stock more recently. UiPath has said that AI will raise demand for its robotic process automation technology, which automates certain tasks.

Gitlab (GTLB) delivered earnings and revenue surprises of +33.33% and +4.74%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

Both UiPath and ServiceNow are betting on AI automation, but only one has the stronger position.

A number of stocks jumped in the afternoon session after quarterly earnings and upbeat corporate commentary signaled that artificial intelligence is driving growth across enterprise software rather than threatening legacy business models.

Salesforce's blowout quarter sent shockwaves through software stocks that never reported a single number this week, and the names catching the biggest bids are some of the most beaten-down agentic-AI plays in the market.

Rezolve AI scored a validation win so rare for small-cap AI names that it sent the stock surging 22% in a single session, yet the same announcement barely moved the needle for its hyperscaler partner. Now traders are deciding how much of that move was real.

One company just turned profitable on a 17.5% net margin; the other commands 97% of Fortune 500 but carries $31.5B in debt.

Palantir's surging AI demand, government strength and modular sales model give it the edge over UiPath despite its richer valuation.
Although UiPath (currently trading at $13.59 per share) has gained 5.4% over the last six months, it has trailed the S&P 500’s 11.7% return during that period. This may have investors wondering how to approach the situation.
Agentic AI software names are moving together this Friday afternoon, and the leaderboard looks like a mirror image of Monday’s session. Palantir (NASDAQ:PLTR) stock is surging 10% to $170.76 midday, while UiPath (NYSE:PATH) shares are climbing 7% to $14.93 and C3.ai (NYSE:AI) shares are rallying 5% to $10.43. The iShares Expanded Tech-Software Sector ETF (CBOE:IGV) ... Palantir Surges 10%, UiPath Rises 7%, C3.ai Gains 5% as Agentic AI Stocks Rally Together
Palantir‘s (NASDAQ:PLTR) stock is ripping higher early Tuesday, with Palantir shares up 16% to $145.50 after the company posted a blowout Q2 2026 and raised its full-year outlook. The rally follows Monday’s after-close earnings release, and it hasn’t spread to peer agentic-AI names. The bounce comes off a rough stretch. Palantir stock was down 29% ... Palantir Rockets 16% After Q2 Blowout; C3.ai, UiPath Sit Out the Rally
Marvell trades at a premium valuation with higher growth, while UiPath offers a cheaper entry point with a lower growth profile.
UiPath trades at a 15.4x forward P/E with positive net income, while Snowflake's 29% revenue growth comes at a $1.3 billion annual loss.
UiPath's stock has been left for dead, yet several of enterprise software's biggest players have compelling reasons to want it. Five names stand out as potential acquirers, and the logic behind one of them is almost impossible to argue against.
The robotic process automation and agentic AI specialist is a cheap growth stock that just got cheaper.
NVIDIA boasts a 55.6% net margin and $96.7 billion in free cash flow, while UiPath trades at a fraction of the valuation despite turning profitable.
Today, July 17, 2026, this week's AI pricing deal with a U.K. retailer boosted the stock as the automation provider navigates revenue headwinds.
Agentic AI is a compelling long-term opportunity.
PATH's AI orchestration push and growing enterprise adoption make it a more compelling buy over NU despite Nubank's strong fintech growth.
